ArticleJournal of materials chemistry. B2026
Ultrafast-light driven plasmonic inactivation of
Article in Journal of materials chemistry. B, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Biofilm infections and antimicrobial resistance are growing problems that necessitate alternative strategies to supplement or replace antibiotic drugs. Plasmonic antimicrobials utilize localized thermal, chemical and photophysical responses to the optical excitation of localized plasmons in noble metal nanostructures for microbial inactivation. High fluence femtosecond pulsed laser excitation of noble metal nanoparticles allows for highly non-linear physics and gives rise to a wide range of physico-chemical phenomena, such as plasma, reactive oxygen species generation, and nanocavitation, which also have antibacterial implications. In this work, we irradiate lipid functionalized gold nanorods that have a longitudinal plasmon resonance at 710 nm bound to Gram-positive
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.